An Efficacy and Safety Study of shRNA-modified CD34+ Cells in HIV-infected Patients.
Status:
Recruiting
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the efficacy and safety of autologous CD34+ cells
that stably express multiplexed shRNA to treat HIV infection.